The INTRICATE program has brought forward a strategic technology platform to develop device candidates for chronic degenerative diseases in the field of musculoskeletal disease (rheumatology, orthopaedics).
Using several building blocks, focussed around game-changing biopolymers, this unique platform aims to generate device candidates with selectable mechanical properties.
These assets achieve their primary effect through mechanical action.